COVID-19 Resources

CORONAVIRUS

Resources

We’ve gathered some resources from around the nation to support organizations, employees, and individuals through the COVID-19 pandemic.

Resources from the Substance Abuse & Mental Health Services Administration.

Relevant resources from other federal agencies.

STATE RESOURCES

Relevant resources from state agencies arount the nation.

OTHER AGENCIES

Relevant resources from non-government agencies.

SAMHSA’s COVID-19 Guidance and Resources

SAMHSA recognizes the challenges posed by the current COVID-19 situation and is providing the following guidance and resources to assist individuals, providers, communities, and states across the country. SAMHSA stands ready to assist in any manner possible. Visit SAMHSA COVID-19 Resource Page for the most current information and resources.

SAMHSA COVID-19 Resource Page

Here are some handpicked resources from SAMHSA we thought would be helpful.

2021 GRANTS

SAMHSA Funded Grants for FY 2021

2020 GRANTS

Updated SAMHSA Funded Grants for FY 2020

LETTER TO TREATMENT PROVIDERS

Letter to Providers on PPE

OPIOID TREATMENT GUIDANCE

Opioid Treatment Program (OTP) Guidance

GUIDANCE FOR OTP PATIENTS

OTP Guidance for Patients Quarantined at Home with the Coronavirus

FAQs

FAQs: Provision of Methadone and Buprenorphine for the Treatment of Opioid Use Disorder in the COVID-19 Emergency

Federal Resources

We’ve put together a list of other federal resources.

DEA DIVERSION CONTROL DIVISION

COVID-19 information and resources.

CDC AND FEMA

CORONAVIRUS.GOV

CDC

CDC COVID-19 Index

US GOVERNMENT

What is the US Government doing?

Similar Posts

  • NAMA SITE SEARCH

    Admin 04/08/2022

    Search the NAMA site with Digital Equipment Corporation’s excellent ALTAVISTA search engine! Just type your search term(s) next to the text Reading “url:Methadone.org” Search for:    NOTE: This search takes you away from our site. Either use your browser’s “Back” button or choose one of the results returned by AltaVista to continue with us.  

  • Orlaam(LAAM) Alert

    Admin 06/17/2021

    FDA Warns About Orlaam T01-15 Print Media: 301-827-6242 April 20, 2001 Broadcast Media: 301-827-3434   Consumer Inquiries: 888-INFO-FDA The U.S. Food and Drug Administration (FDA) issued a new warning about health risks associated with levomethadyl acetate HC, a.k.a. Orlaam, a drug used to treat opiate addiction. FDA Announces Labeling Changes Following Cardiac Adverse Events With…

  • Events

    Admin 11/01/2022

    AMTA Conference 2000 American Methadone Treatment Association April 9-12, 2000 San Francisco Preconference Meeting How Can We Develop and Strengthen Patient Advocacy Groups? Day: Sunday Date: April 9, 2000 Time: 1 – 5 PM Moderator: John Finger, TexNAMA Presenters: Joycelyn Woods, NAMA Diane Fleury-Seaman, MALTA Fred Christie, AFIRM James DePasquale, Membership Director/Chapter Coordinator of NAMA…

  • The Pharmacology of Opioids

    Admin 04/18/2023

    Basic Pharmacology:  How Methadone Works Part 2 Basic Opioid Pharmacology All natural and synthetic opioids exhibit a three dimensional T-shaped configuration (Barchas, Berger, Ciaranello and Elliott, 1977). This T-shaped molecule has two broad hydrophobic surfaces which are at right angles and a methylated nitrogen which is usually charged at physiological pH. The charged nitrogen is…

  • NAMA’s Comments to State Medical Board Model Policy Guidelines

    Admin 10/22/2021

    National Alliance of Methadone Advocates 435 Second Avenue New York, NY 10010 Phone: (212) 595-6262 Review Guidelines for the Federation of State Medical Boards Model Policy Guidelines for Opioid Addiction Treatment in the Medical Office Section I Preamble Paragraph 2 The second sentence should also include the fact that Medical Maintenance has been demonstrated to…